Northside Capital Management LLC cut its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,151 shares of the pharmacy operator’s stock after selling 250 shares during the quarter. Northside Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $451,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. First Trust Advisors LP raised its position in Walgreens Boots Alliance by 76.5% in the first quarter. First Trust Advisors LP now owns 1,460,684 shares of the pharmacy operator’s stock worth $92,417,000 after acquiring an additional 632,919 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in Walgreens Boots Alliance in the 1st quarter worth about $380,000. OppenheimerFunds Inc. increased its stake in Walgreens Boots Alliance by 63.2% in the 1st quarter. OppenheimerFunds Inc. now owns 246,282 shares of the pharmacy operator’s stock worth $15,582,000 after purchasing an additional 95,365 shares in the last quarter. Advisory Alpha LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter worth about $74,000. Finally, Andra AP fonden purchased a new position in Walgreens Boots Alliance in the 1st quarter worth about $6,447,000. Institutional investors and hedge funds own 59.69% of the company’s stock.
NASDAQ:WBA traded up $1.34 on Friday, hitting $54.27. 2,656,024 shares of the company’s stock traded hands, compared to its average volume of 4,809,040. The company has a current ratio of 0.76, a quick ratio of 0.37 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance Inc has a 1 year low of $49.03 and a 1 year high of $86.31. The firm has a 50-day moving average price of $53.03 and a 200-day moving average price of $53.71. The company has a market cap of $47.04 billion, a PE ratio of 9.01, a price-to-earnings-growth ratio of 1.32 and a beta of 0.89.
A number of equities analysts recently weighed in on WBA shares. Cleveland Research reissued a “hold” rating on shares of Walgreens Boots Alliance in a research note on Monday, September 9th. Bank of America dropped their price target on Walgreens Boots Alliance from $51.00 to $50.00 and set an “underperform” rating on the stock in a research note on Thursday, October 3rd. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Wednesday, September 11th. ValuEngine raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Wednesday, October 2nd. Finally, Morgan Stanley dropped their price target on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research note on Friday, August 23rd. Seven equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $62.24.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Recommended Story: What is the Gross Domestic Product (GDP)?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.